 VHHs against GFAP have been obtained by Ribosome display after immunization of one alpaca with GFAP  VHHs against GFAP have been obtained by phage display after immunization of another alpaca with a human brain extract containing GFAP  All the VHHs were closely related and one VHH was found to be strictly identical in both studies.
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Introduction
Besides producing conventional tetrameric antibodies, camelids also display functional antibodies composed of homodimerized heavy chains. These antibodies lacking light chains, interact with antigens by the virtue of only one single variable domain of the heavy chain, referred to as VHH to distinguish it from VH of conventional antibodies [1] . VHHs possess a number of advantages for antibody engineering when compared with the conventional antibody fragments (Fab: Fragment antigen-binding or scFv: Single-chain variable fragment). VHHs are highly soluble and can be expressed at high levels in the periplasm and the cytoplasm of E.
coli and eukaryotic cells [2, 3] . Due to their relatively small size (14-17 kDa), VHHs offer also many advantages in terms of structural analysis and in diagnostic applications requiring tissue penetration [2] [3] [4] [5] [6] [7] [8] [9] . Achour I et al, 2008 [10] Phage and ribosome display are ideal tools of widespread use for the selection of different antibody fragments [11, 12] . Phage display was first described by Smith [13] and McCafferty et al [14] used it successfully for the selection of antibodies for the first time in 1990. Compared with other display technologies, phage display possesses many advantages: robustness, simplicity and stability of the phage particles and the selection can be performed on cell surface, tissue sections and in vivo [15] [16] [17] [18] .
However, phage-display libraries sizes are restricted to 10 10 -10 11 by the efficiency of bacterial transformation. In vitro display technologies have since been developed as an alternative, the most widely used being ribosome display [19] . Hanes et al successfully selected antibody fragments by using this method in 1998 and 2000 [20, 21] . Despite many improvements made recently, ribosome display is still challenging to perform for selection on cell surfaces or against non-purified antigens.
On the other side, a strong advantage of ribosome display over phage display, is that the encoded DNA does not need to be imported into a host because DNA amplification and protein synthesis occurs totally in vitro. As a consequence, ribosome display libraries can allow more diversity with possibly more than 10 13 binders [12] .
Here we wanted to compare VHHs directed against the same protein obtained from two immune libraries by using the two pre-cited most-used selection techniques for antibody screening. The bound alpaca antibodies were detected with polyclonal rabbit anti-alpaca IgGs [23] . The same procedure was performed on a murine brain extract. The extract was referred to as mWT45.
Library construction, selection and expression of VHH
The blood of the animal immunized with the human brain extract was collected. The selection of cDNA coding only for VHH were realized according to Lafaye et al, 5 2009, 1995 [23, 24] . The vhh genes were then cloned into phagemid vector pHEN1 by using primers contained enzymatic NcoI and NotI restriction sites at the 5' and 3'ends, respectively. The size of the library was 3x10 8 cfu.
Phage display protocols were performed as described in Lafaye et al, 2009 [23] .
Briefly10
13 phage-VHH diluted in PBS were used to perform a panning cycle by using saturated Nunc immunotubes (InterMed) coated with human brain extract (10 µg/ml). To increase the stringency, different blocking buffers for each panning were used: 2% skimmed milk as saturating agent for the first round; 5% BSA (Bovine Serum Albumin) and Odyssey blocking buffer (LI-COR Biosciences) diluted at ¼ for the second and third one.
Sixty-one individual clones were randomly chosen and tested by ELISA against Sg4697 and BSA. The DNA corresponding to the positive VHHs was sequenced by GATC Biotech. The sequences were processed with DNA strider and analyzed using ClustalW2-Multiple Sequence Alignment of EMBL-EBI.
The blood of the animal immunized with GFAP was collected and selection of cDNA coding for VHH was performed as described earlier.
The vhh population was converted to ribosome display format using PCR and transcribed to mRNA [8] .
Selection of ternary complexes involving mRNA, ribosome and functional VHH was performed on GFAP as described by Perruchini et al, 2009 [8] .
The VHH sequences were analyzed at the genomic level using IMGT (International ImMunoGeneTics information system) alpaca genomic database.
To summarize, the VHHs A12, G110, C5F7, C7G7, B70, B7, G11 and H8 were obtained by phage display, the VHHs E9, E3 and A10 were obtained by ribosome display. and washed prior the addition of rabbit anti-alpaca Ig followed by peroxidaseconjugated goat anti-rabbit Igs (ICN biomedicals).
A competition assay was performed to determine VHH-binding sites. Various concentrations of His-Tagged VHH H8/E9 was incubated into wells coated with GFAP for 1 h at 37°C. Plates were washed and strep-tagged VHHs (H8/E9, B7 and G11) were added. After additional incubation for 1 h at 37°C, the presence of the strep-tagged VHHs was revealed by the addition of an home-made anti-strep tag mAb (eBioscience) followed by peroxidase-conjugated goat anti mAb (ICN biomedicals).
Western Blot
To control the VHH specificity by WB, 10 µl of diluted (1:10) Sg4697 human and mWT45 mouse brain extracts and 1µg of human GFAP (USBiological) were used.
Protein samples were treated at 70°C for 10 min in reducing conditions. Following the separation by polyacrylamide gel electrophoresis (PAGE) using NuPAGE Novex 4-12% Bis-Tris gels, semi-dry transfer onto Hybond-C (Amersham) was performed, the membranes were blocked in a 4% skimmed milk solution. Purified strep-tagged VHHs (1 µg/ml) were used as primary antibodies at 4°C overnight. An in-house antistrep tag mouse mAb (C23-21) was added at 1 µg/ml and incubated for 1h at 37°C.
Peroxydase-labeled goat anti-Mouse Ig 1:10000 (Vector) was added and incubated for 1h at 37°C. Finally, peroxidase activity was visualized using a chemiluminescent kit (Amersham).
Immunohistochemistry
Adult C57BL6 mice were euthanized by intraperitoneal injection of sodium 
Measurement of VHH affinity
Affinity was measured in solution [8, 25] . Briefly, VHH samples were incubated overnight with increasing amounts of GFAP (Millipore) at concentrations ranging from 10 -11 to 10 -7 M. The remaining free antigen binding sites were then quantified by ELISA using an anti-His tag mAb, followed by an anti-mouse -galactosidase conjugate and 4-methylumbelliferyl  -D galactoside substrate. Fluorescence was read at 460 nm after excitation at 355 nm. KD was estimated from the slope of the regression curve obtained by plotting the reciprocal of the fraction bound antibody versus the reciprocal of the molar concentration of the antigen. were sequenced, revealing only 8 different sequences, A12, G110, C5F7, C7G7, B70, B7, G11 and H8 (Fig. 1 ).
A12 appeared most frequently with 19 occurrences and G110 was found 5 times.
C5F7 and C7G7 appeared both 3 times. B70 was detected only once. B7, G11and H8
(one occurrence each) share the same CDRs.
We analyzed the biochemical properties of these VHHs obtained from the phage display library. After cloning in pASK vector and periplasmic expression, the purified VHHs with a strep-tag at the C-terminus were obtained. Until now, for A12, B70, C7G7, G110 and C5F7 no accurate antigen target has been identified in immunohistochemistry using mouse brain tissue.
Interestingly, we found that the new VHHs B7, H8 and G11 obtained by phage display are closely related to the anti-GFAP VHHs previously isolated after ribosome display screening. Indeed, another alpaca was immunized with purified human GFAP.
Lymphocytes and VHH corresponding DNA were isolated, the VHH-coding mRNA sequences were selectively amplified. Three VHHs (E9, E3 and A10) with a high affinity for GFAP and their corresponding cDNA were selected by ribosome display [8] (Fig. 2) . Also, one VHH with strictly identical sequence was isolated by the two procedures (H8 and E9 [8] , respectively) ( Fig. 1) .
As the recovery of a same VHH from two different animals with two different methods was totally unexpected we then analyzed the polyclonal serum of both alpacas for their ability to recognize GFAP by ELISA (Fig. 3) . Notably, the serum of 9 the alpaca immunized with the brain extract did recognize GFAP, although with a slight reactivity, while the polyclonal serum of the alpaca immunized with GFAP presented a high titer of anti-GFAP, as expected. In parallel we used a polyclonal serum taken from a third alpaca which had never been immunized with human GFAP.
No GFAP recognition was observed with this serum. The low titer of GFAP-specific antibodies in the serum of the animal immunized with human brain extract also emphasized the efficiency of the phage display selection method to recover minor clones.
Biochemical characterization of the anti GFAP VHHs
Western blot experiment was performed with VHHs H8/E9, B7 and G11. Three samples were analysed: human brain extract (Sg4697), C57B/6 adult wild type mouse brain extract (mWT45) and the purified GFAP. WB analysis showed that the different VHHs labelled several bands between 35 and 55 kDa in human brain extract (Fig. 4A) .
Similar outcomes had already been observed by immunoblot using anti-GFAP antibodies on human brain extract, due to different isoforms of the protein in humans [8, 26] . The VHHs labelled one band just below 55 kDa in mouse brain extract, in accordance with the fact that only one main isoform is expressed in mice (Fig. 4A ).
They also recognized the GFAP protein as a positive control (Fig. 4B ).
To determine whether the VHHs recognized the same epitope, competition among the 3 VHHs for binding to GFAP was carried out as described in "Materials and
Methods". The binding of strep-tagged VHHs decreased as a function of increasing concentrations of the his-tagged VHH H8/E9 (Fig 5) , suggesting that VHHs recognize the same epitope, or at least closely related epitopes, on GFAP.
H8/E9, B7 and G11 obtained either after immunization with purified human GFAP or with human brain extract strongly and specifically immunodetected GFAP in astrocytes in mouse brain tissue (Fig. 6) , which was normally expected, as mouse GFAP protein showed 91% sequence identity to that of human [27] .
The affinity of VHHs obtained by the two methods was measured by ELISA [8, 25] .
A10, E9, H8 and G11 had affinities in the nanomolar range while the affinity of E3 10 was in the micromolar range and B7 had an affinity of 7.1x10 -10 M, 8-fold higher than the affinity of VHH H8 and VHH E9 respectively (Table 1) .
For E3, the presence of a proline at position 25 instead of a serine probably induced a modification of the CDR1 loop as proline is usually found in sharp turns [8, 28] . This modification could alter E3 functionality as reflected by the sharp decrease of its affinity for GFAP. B7 had a higher affinity when compared to other VHHs. The differences between B7 and both VHHs H8 and E9 were Leu11, Glu13 and Ala89 in B7 instead of Ser11, Gln13 and Glu89 in H8/E9 (Fig. 1) , This was associated to local charge modifications in B7: an extra negative charge introduced at position 13 and a negative charge removed at position 89. These features might positively influence VHH binding by modifying the structure of CDRs or by involving some amino acids of framework (FR) in interacting with the antigen.
Obtaining VHHs with VH characteristics
The gene segment families were identified by a search for similarities in IMGT. The nucleotide sequence of VHHs showed a 90% sequence similarity with a single V gene referred to as IGHV3S31 (accession number AM939730 [10] ) which is classified as a VH gene [10] The junction segment JH of VHH corresponded to IGHJ4 genetic element [29] . No D gene was found according to IMGT analysis.
Obtaining VH from immune VHH libraries was unexpected, but some studies demonstrated that a minority (5-10%) of VHH originates from VH germline genes, which have been identified together with canonical VHH in immune libraries [7, 30] .
In FR2 regions, VH possess the conserved Val37, Gly44, Leu45 and Trp47, which are clustered in space and these VH amino acid hallmarks form a hydrophobic bond with the VL [31, 32] . In VHH, these amino acids are often substituted (Val37Phe or Val37Tyr, Gly44Glu, Leu45Arg and Trp47Gly) [33] . We found for all anti-GFAP VHHs Gly44 and Trp47 which are VH conserved amino acids. At positions 37 and 45, instead of a valine and a leucine we respectively found a leucine and an isoleucine which are closely related amino-acids (Fig. 1) . Moreover Trp118 was substituted by an arginine, a feature usually observed when conventional VH3 genes recombine with a D-JH and are expressed as homodimeric IgG [34, 35] . 
Discussion
Similar VHHs directed against GFAP were isolated with two different selection methods and from two different animals immunized with two different antigenic preparations based on GFAP-containing human brain extract vs purified GFAP (Fig. 2) We can exclude possible contamination between the two immune libraries, first because experiments were not performed simultaneously. The selection of H8 by phage display is recent while the selection of VHH E9 by ribosome display with the other immune library was made previously [8] . Also the selection of the two antibodies was performed using a completely distinct process with no common reagents or common steps.
Using an immune library is an important factor for successful selection and retrieval of high affinity antibodies [15] . Following the immunization with an antigen, the specific B cells will proliferate and undergo affinity maturation for the antigen. Polystyrene plates were coated with GFAP. His tagged VHH E8/H9 at different concentrations was added, followed by strep-tagged VHH H8/E9, B7, and G11 and revealed by an anti-strep tag mAb. 
